
    
      The planned study duration is approximately 16 months.

      The total duration of study participation is approximately 34 weeks including up to a 2-week
      screening period, a 2-week run-in period, a 16-week treatment period, and a follow-up visit
      14 weeks after the final treatment visit.
    
  